glp 1 agonist metformin Clinical Focus on GLP-1 Agonists in Type 2 Diabetes Mellitus Diagram summarizing how metformin, gliclazide,
Description
Extending its duration of action has become a key focus in drug development
According to a report by the Ministry of Health and Family Welfare, over 30% of patients express a preference for therapies specifically customized to their health profiles and genetic markers
To ensure a fair comparison and reduce bias, the researchers performed a one-to-one case-control matching
[DOI] [Google Scholar] 27.Jia G., Hill M
Add more beans to your diet
[DOI] [PMC free article] [PubMed] [Google Scholar] 41.Harkavyi A., Abuirmeileh A., Lever R., Kingsbury A.E., Biggs C.S., Whitton P.S
